Pam Belluck
Posts
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risks
The agency is expected to decide this summer whether to allow the first nonprescription sales of an oral contraceptive in the United States.
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.
Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market
The suit by GenBioPro, the generic maker of mifepristone, is the latest strand in the intense legal battle over abortion pills.
Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictions
The judges blocked the drug from being sent to patients through the mail and rolled back other steps the government had taken to ease access.
What’s Going On With the Abortion Pill Rulings by Federal Judges?
One invalidated the F.D.A.’s approval of the abortion pill mifepristone. The other ordered the F.D.A. to do nothing to restrict the pill’s availability.
Texas Judge Invalidates FDA Approval of the Abortion Pill Mifepristone
The Texas judge’s ruling was quickly contradicted by another federal judge in Washington State who ordered the F.D.A. to keep mifepristone available.
Wyoming Judge Temporarily Blocks the State’s New Abortion Ban
Wyoming’s Constitution guarantees a right to make individual health care decisions. The new ban attempts to circumvent that right by declaring that abortion is not...
Lawyers to Face Off Before Judge in Closely Watched Abortion Pills Case
The first hearing in a lawsuit that seeks to overturn F.D.A. approval of the pills takes place Wednesday morning in Texas.
Walgreens Says It Won’t Offer the Abortion Pill Mifepristone in Conservative States
The decision applies to 21 states whose attorneys general threatened Walgreens and other pharmacies with legal action if they dispensed the pill there.
12 States Sue F.D.A., Seeking Removal of Special Restrictions on Abortion Pill
The suit argues that rules applying to mifepristone unnecessarily limit patients’ access to medication abortion.